Metabolic Checkpoints in IgA Nephropathy: From Pathogenesis to Precision Medicine

Puntos clave

• IgA nephropathy progression is linked to specific metabolic checkpoints, enhancing understanding of the disease.
• Key metrics highlight potential biomarkers that can guide personalized treatment approaches in IgA nephropathy.
• Assessment using metabolic profiling reveals insights into the pathogenesis of IgA nephropathy, advancing therapeutic options.
• This work may enable the translation of findings into clinical practice, emphasizing the need for tailored therapies.